Тезепелумаб Астразенека

Amgen, AstraZeneca's tezepelumab is looking for...

(PDF) Tezepelumab as an Emerging Therapeutic Op...

AstraZeneca buys US lung drug firm Pearl Therap...

Tezepelumab Regulatory Submission Accepted and ...

Tezepelumab Shows Potential for COPD, Negative ...

By IPP Bureau | June 22, 2024

Купить Тецентрик (Атезолизумаб) - Tecentriq (At...

Tezepelumab Could Help Amgen Develop Its Inflam...

US FDA approves Amgen-AstraZeneca’s Tezspire fo...

By IPP Bureau | September 10, 2024

AstraZeneca to acquire TeneoTwo and its clinica...

FDA Approves Tezepelumab for Self-Administratio...

Tezepelumab Benefits Asthma Patients Year-Round...

Tezepelumab Effective in Severe Asthma Cohorts ...

Is Tezepelumab approved by the FDA?

What is Tezepelumab? Side Effects, Benefits, an...

(PDF) [Tezepelumab: a new option for the treatm...

Two key AstraZeneca medicines accepted for use ...

AstraZeneca severe asthma treatment Tezspire ge...

AstraZeneca shares tumble 15% on big drug trial...

FDA grants priority review to BLA for AstraZene...

US FDA grants priority review to tezepelumab to...

TEZSPIRE® (tezepelumab-ekko) HCP on LinkedIn: D...

AstraZeneca Truqap plus Faslodex recommended fo...

Tezspire (tezepelumab) approved in the European...

AstraZeneca (AZN) Investor Presentation - Slide...

Tezepelumab in patients with allergic and eosin...

Long-term safety and efficacy of tezepelumab in...

Figure 2 from Efficacy and Potential Positionin...

Amgen, AstraZeneca's tezepelumab hits goal in a...

Japan Archives - Clinical Trials Arena

AstraZeneca Welcomes Neurofibromatosis And Asth...

Relief for AZ, Amgen as FDA okays severe asthma...

ДЭМБ “Астразенека” компанийн вакцинаар дархлааж...

АстраЗенека вакцины хоёр дахь тунг энэ сарын 15...